Cirrhosis Clinical Trials in Rochester, Minnesota
7 recruitingRochester, Minnesota
Showing 1–7 of 7 trials
Recruiting
Phase 2
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
Liver Cirrhosis
Boehringer Ingelheim30 enrolled27 locationsNCT07325526
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc.762 enrolled291 locationsNCT06419374
Recruiting
Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
CirrhosisChronic Kidney DiseaseGastric Antral Vascular Ectasia
Mayo Clinic30 enrolled1 locationNCT06306963
Recruiting
Biobank for Cholestatic Liver Diseases.
Liver CancerCholangiocarcinomaPrimary Sclerosing Cholangitis+1 more
Mayo Clinic9,150 enrolled1 locationNCT03445585
Recruiting
Not Applicable
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
CirrhosisHepatic Encephalopathy
Mayo Clinic11 enrolled2 locationsNCT06425380
Recruiting
Phase 2
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
CirrhosisCirrhosis, LiverCirrhosis Due to Hepatitis B+5 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)256 enrolled13 locationsNCT05832229
Recruiting
Phase 1
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
Cirrhosis, LiverLiver FibrosisAscites Hepatic
PharmaIN74 enrolled9 locationsNCT05490888